出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年2月
Pharmaceutical Packaging Market – Global Forecast to 2028
医薬品包装市場 : 原材料 (プラスチック、紙＆板紙、ガラス、金属)、種類 (ペットボトル、ブリスター、キャップと蓋、ラベルと付属品、プレフィルドシリンジ)、薬物送達、地域別 – 2028年までの世界予測
Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled Syringes), Drug Delivery, and Region – Global Forecast to 2028
| ページ数 | 299 |
| 図表数 | 326 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
The market for pharmaceutical packaging is approximated to be USD 132.0 billion in 2023, and it is projected to reach USD 269.9 billion by 2028 at a CAGR of 15.4%.
医薬品包装市場は 2023 年に 1,320 億米ドルと推定され、CAGR 15.4% で 2028 年までに 2,699 億米ドルに達すると予測されています。
The increasing demand for pharmaceutical packaging is driven by the surge in healthcare expenditures, necessitating a higher requirement for various packaging products such as strip packs, aerosol generators, collapsible tubes, canisters, implants, and blister packs. Technological advancements in the pharmaceutical packaging industry have given rise to innovative solutions such as smart packaging and sterile packaging, contributing to the overall growth of the market.
“By Type, Labels & accessories accounted for the third highest CAGR during the forecast period.”
The labels & accessories market is experiencing significant growth driven by the pharmaceutical packaging market. Labels & accessories in pharmaceutical packaging play a critical role in ensuring the safety, efficacy, and proper usage of medications. Labels play a crucial role in conveying vital information about a product, encompassing dosage instructions, expiration dates, and lists of ingredients. Additionally, labels aid in the identification and comprehension of the product, enhancing patient safety and ensuring compliance with regulatory standards. Accessories such as tamper-evident elements and child-resistant packaging are specifically crafted to safeguard products and deter unauthorized access, especially for medications carrying a risk if consumed by children or if the product’s integrity is compromised.
“By Packaging Type, Primary packaging is the fastest growing packaging type during the forecast period.”
The primary packaging is the first and initial layer of packaging directly in contact with the drug and holds significant importance in preserving the quality and effectiveness of pharmaceutical products. This market encompasses diverse forms of packaging, including ampoules, vials, containers, strip packaging, blister packaging, syringes, bottles, and sachet packaging. The evolution of drug delivery systems frequently requires innovative primary packaging solutions to support novel administration methods, including prefilled inhalers, syringes, and other specialized devices. These factors drive the primary packaging segment in the pharmaceutical packaging market.
“By Drug Delivery, Injectables accounted for the second largest market during the forecast period.”
Injectable drug delivery modes are recognized as highly effective and successful routes of drug administration due to their rapid and efficient delivery to the target area. While most drugs are administered orally or through injections, injectables come in various forms such as self-injection devices, prefilled syringes, auto-injectors, safety syringes, patch injectors, pen injectors, and more. The growth of the biologics market is also anticipated to contribute to the expansion of the injectables market in the forecast period.
“By Raw Material, Paper & paperboard accounted for the second largest market share during the forecast period.”
Paperboard materials are widely used for secondary pharmaceutical packaging, such as cartons, blister wallets, and rigid boxes, due to their greater surface area and improved product display. The attributes of the paper substrate, such as surface properties, color, brightness, opacity, basis weight, grain direction, tensile strength, and tearing strength, are important considerations in the production of paperboard packaging. Anticipated future developments in paper and paperboard for pharmaceutical packaging, focusing on aspects such as branding, labeling, patient adherence functionality, braille compliance features, and the inclusion of regulatory information, are expected to contribute to market growth. There is a notable demand for visually appealing prints on paper-based packaging, further fostering the expansion of this segment.
“Europe is projected to account for the second largest market share in the pharmaceutical packaging market during the forecast period.”
In Europe, there is a growing demand for primary packaging products driven by advanced drug delivery modes such as prefilled inhalers and pre-filled syringes. Additionally, caps & closures, blister packs, and specialty bags contribute to the growing demand for primary packaging in the region. The rising demand for pharmaceutical packaging in the European region is driven by the growing activities in pharmaceutical research, production, and distribution. Significant advancements in the field of medical biopharmaceuticals are further boosting the market in the region. The pharmaceutical packaging industry has witnessed consistent growth in countries such as Germany, France, and the UK, owing to their health-conscious population.
Primaries-
By Company Type: Tier 1: 25%, Tier 2: 50%, and Tier 3: 25%
By Designation: C-level Executives: 30%, Directors: 20%, and Others: 50%
By Region: North America: 20%, Europe: 30%, Asia Pacific: 25%, Latin America: 15%, and Middle East & Africa: 10%
Companies Covered: Berry Global (US), Amcor Plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), and AptarGroup, Inc. (US) are some of the established players in the pharmaceutical packaging market.
Research Coverage
The market study covers the pharmaceutical packaging market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on type, packaging type, raw material, drug delivery, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the pharmaceutical packaging market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall pharmaceutical packaging market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses and plan suitable go-to-market strategies.
The report provides insights on the following pointers:
• Analysis of drivers (the rising demand for pharmaceutical packaging in the pharmaceutical industry), restraints (raw material cost of pharmaceutical packaging products), opportunities (growing demand for sustainable packaging), and challenges (safeguarding against counterfeit products in pharmaceutical packaging) influencing the growth of pharmaceutical packaging market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and mergers & acquisitions in the pharmaceutical packaging market.
• Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for pharmaceutical packaging market across regions.
• Market Diversification: Exhaustive information about new products % services, untapped geographies, recent developments, and investments in the pharmaceutical packaging market
• Market Penetration: Comprehensive information on the pharmaceutical packaging market offered by top players in the global market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the pharmaceutical packaging
Table of Contents
1 INTRODUCTION 39
1.1 STUDY OBJECTIVES 39
1.2 MARKET DEFINITION 39
1.3 INCLUSIONS & EXCLUSIONS 40
TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS 40
1.4 STUDY SCOPE 41
FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION 41
1.4.1 REGIONS COVERED 42
FIGURE 2 REGIONAL SCOPE 42
1.4.2 YEARS CONSIDERED 42
1.5 CURRENCY CONSIDERED 43
1.6 UNITS CONSIDERED 43
1.7 STAKEHOLDERS 43
1.8 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key secondary sources 45
2.1.1.2 Key data from secondary sources 46
2.1.2 PRIMARY DATA 46
2.1.2.1 Key primary sources 47
2.1.2.2 Key data from primary sources 47
2.1.2.3 Key industry insights 48
2.1.2.4 Breakdown of primary interviews 48
2.2 MARKET SIZE ESTIMATION 49
2.2.1 BOTTOM-UP APPROACH 49
FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH 49
2.2.2 TOP-DOWN APPROACH 49
FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH 49
2.3 DATA TRIANGULATION 50
FIGURE 6 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION 50
2.3.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY SOURCES 51
2.3.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES 51
FIGURE 7 PHARMACEUTICAL PACKAGING MARKET ANALYSIS 52
2.4 RESEARCH ASSUMPTIONS 52
2.5 FACTOR ANALYSIS 53
2.6 GROWTH ESTIMATION 53
2.6.1 SUPPLY SIDE 53
2.6.2 DEMAND SIDE 53
2.7 LIMITATIONS & RISKS 54
2.8 RECESSION IMPACT 54
3 EXECUTIVE SUMMARY 55
FIGURE 8 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 56
FIGURE 9 PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 57
FIGURE 10 ORAL DRUG DELIVERY MODE TO DOMINATE MARKET DURING FORECAST PERIOD 57
FIGURE 11 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD 58
FIGURE 12 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 59
4 PREMIUM INSIGHTS 60
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET 60
FIGURE 13 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 60
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 61
FIGURE 14 PREFILLED SYRINGES TO RECORD FASTEST GROWTH DURING
FORECAST PERIOD 61
4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 61
FIGURE 15 PLASTICS SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 61
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY 62
FIGURE 16 INJECTABLES SEGMENT TO BE FASTEST-GROWING MARKET BY 2028 62
4.5 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 62
FIGURE 17 PRIMARY SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 62
4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY 63
FIGURE 18 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET 64
5.2.1 DRIVERS 65
5.2.1.1 Surge in healthcare expenditure and growth of pharmaceutical industry 65
5.2.1.2 Rising demand for drug delivery devices and blister packaging 66
5.2.1.3 Technological advancements in pharmaceutical packaging 67
5.2.1.3.1 Nanomedicine and nano drug delivery systems 67
5.2.1.3.2 Child-resistant packaging 67
5.2.1.3.3 Radio-frequency identification 67
5.2.1.3.4 Micro-pump technology 68
5.2.1.3.5 Eco-friendly and sustainable packaging 68
5.2.2 RESTRAINTS 68
5.2.2.1 Surge in packaging costs due to dynamic regulatory policies 68
5.2.2.2 Restricted access to healthcare systems in emerging economies 69
5.2.3 OPPORTUNITIES 69
5.2.3.1 Growing demand for primary pharmaceutical packaging 69
5.2.4 CHALLENGES 70
5.2.4.1 Safeguarding against counterfeit products 70
5.3 VALUE CHAIN ANALYSIS 71
FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS 71
5.3.1 RAW MATERIAL SUPPLIERS 71
5.3.2 R&D OF PRODUCTS 72
5.3.3 MANUFACTURERS 72
5.3.4 DISTRIBUTORS 72
5.3.5 END USERS 72
5.4 PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 21 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET 73
5.4.1 THREAT OF NEW ENTRANTS 73
5.4.2 THREAT OF SUBSTITUTES 74
5.4.3 BARGAINING POWER OF BUYERS 74
5.4.4 BARGAINING POWER OF SUPPLIERS 74
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 75
TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET 75
5.5 MACROECONOMIC INDICATORS 75
5.5.1 GLOBAL GDP TRENDS 75
TABLE 3 TRENDS OF PER CAPITA GDP (USD), 2019–2021 76
TABLE 4 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027 76
TABLE 5 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2020 77
5.6 TARIFF & REGULATORY LANDSCAPE 78
5.6.1 REGULATIONS 78
5.6.1.1 Europe 78
5.6.1.2 US 78
5.6.1.3 Others 79
5.6.2 STANDARDS 79
5.6.2.1 ISO 9001 79
5.6.2.2 ISO 22000 79
5.6.2.3 ASTM D3475 79
5.6.2.4 USP (United States Pharmacopeia) Standards 79
5.6.2.5 Child-resistant Packaging Standards 79
5.6.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.7 TECHNOLOGY ANALYSIS 80
5.7.1 NANOTECHNOLOGY 81
5.7.2 PACKAGING FOR BIOLOGICS 81
5.7.3 SMART PACKAGING 81
5.7.4 ANTI-COUNTERFEIT PACKAGING 81
5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES 82
5.8 PRICING ANALYSIS 82
5.8.1 AVERAGE SELLING PRICE, BY REGION 82
FIGURE 22 AVERAGE SELLING PRICE, BY REGION (USD/KG) 83
5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL 83
TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG) 83
5.9 ECOSYSTEM/MARKET MAP 84
FIGURE 23 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING 84
TABLE 8 PHARMACEUTICAL PACKAGING MARKET: ROLE IN ECOSYSTEM 85
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 86
FIGURE 24 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE FUTURE GROWTH 86
5.11 PATENT ANALYSIS 86
5.11.1 INTRODUCTION 86
5.11.2 METHODOLOGY 86
5.11.3 DOCUMENT TYPES 87
FIGURE 25 PATENTS REGISTERED (2012–2022) 87
5.11.4 PUBLICATION TRENDS 87
FIGURE 26 NUMBER OF PATENTS IN LAST 10 YEARS, 2012–2022 87
5.11.5 INSIGHTS 88
5.11.6 JURISDICTION ANALYSIS 88
FIGURE 27 TOP JURISDICTIONS 88
5.11.7 TOP APPLICANTS 89
FIGURE 28 TOP 10 PATENT APPLICANTS 89
TABLE 9 PATENTS BY SANOFI 89
TABLE 10 PATENTS BY SCHOTT AG 89
TABLE 11 PATENTS BY NOVARTIS AG 90
FIGURE 29 TOP 10 PATENT OWNERS 90
TABLE 12 TOP 10 PATENT OWNERS IN LAST 10 YEARS 91
5.12 RAW MATERIAL ANALYSIS 91
5.12.1 PLASTICS 91
5.12.2 PAPER 91
5.12.3 GLASS 92
5.12.4 METALS 92
5.13 TRADE ANALYSIS 92
5.13.1 IMPORT SCENARIO 92
TABLE 13 REGION-WISE IMPORT TRADE (USD MILLION) 92
FIGURE 30 REGION-WISE IMPORT TRADE (USD MILLION) 93
5.13.2 EXPORT SCENARIO 93
TABLE 14 REGION-WISE EXPORT TRADE (USD MILLION) 93
FIGURE 31 REGION-WISE EXPORT TRADE (USD MILLION) 93
5.14 KEY CONFERENCES & EVENTS IN 2024–2025 94
TABLE 15 KEY CONFERENCES & EVENTS IN 2023–2024 94
5.15 CASE STUDY ANALYSIS 95
5.15.1 MOISTURE BARRIER TECHNOLOGY FOR EFFICIENT DRUG DELIVERY 95
5.15.2 CUSTOM METERING VALVE FOR INHALERS 95
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 95
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 95
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DRUG DELIVERY MODES 95
5.16.2 BUYING CRITERIA 96
5.16.2.1 Quality 96
5.16.2.2 Service 96
FIGURE 32 SUPPLIER SELECTION CRITERION 96
6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE 98
6.1 INTRODUCTION 99
FIGURE 33 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD 99
TABLE 17 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION) 99
TABLE 18 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION) 100
6.2 PRIMARY 100
6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET 100
6.3 SECONDARY 100
6.3.1 RISING ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND 100
7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 101
7.1 INTRODUCTION 102
FIGURE 34 PLASTICS TO DOMINATE MARKET DURING FORECAST PERIOD 102
TABLE 19 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING 102
TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON) 103
TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON) 103
TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION) 104
TABLE 23 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION) 104
7.2 PLASTIC 104
7.2.1 EFFECTIVE BARRIER PROPERTIES AND COST REDUCTION TO DRIVE MARKET 104
TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 105
TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 105
7.2.2 HIGH-DENSITY POLYETHYLENE 105
7.2.3 POLYESTER 105
7.2.4 POLYPROPYLENE 106
7.2.5 LOW-DENSITY POLYETHYLENE 106
7.2.6 POLYVINYL CHLORIDE 106
7.2.7 CYCLIC OLEFIN COPOLYMER 106
7.2.8 POLYETHYLENE TEREPHTHALATE 107
7.3 PAPER & PAPERBOARD 107
7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET 107
TABLE 26 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 107
TABLE 27 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 108
7.4 GLASS 108
7.4.1 CHEMICAL RESISTANCE AND STURDINESS TO BOOST DEMAND 108
TABLE 28 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 108
TABLE 29 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 109
TABLE 30 GLASS PACKAGING TYPES 109
7.5 METALS 110
7.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET 110
TABLE 31 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 111
TABLE 32 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 111
7.6 OTHER RAW MATERIALS 111
TABLE 33 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 112
TABLE 34 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 112
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY 113
8.1 INTRODUCTION 114
FIGURE 35 ORAL DRUG DELIVERY ACCOUNTED FOR LARGEST SHARE IN 2023 114
TABLE 35 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 115
TABLE 36 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 115
TABLE 37 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION) 115
TABLE 38 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION) 116
8.2 ORAL 116
8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET 116
TABLE 39 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 117
TABLE 40 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 117
8.3 PULMONARY 117
8.3.1 INCREASING CASES OF LUNG DISORDERS TO DRIVE MARKET 117
TABLE 41 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 118
TABLE 42 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 118
8.4 TRANSDERMAL 118
8.4.1 SURGING DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET 118
TABLE 43 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 119
TABLE 44 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 119
8.5 INJECTABLE 119
8.5.1 INCREASING USE OF BIOLOGICS TO BOOST MARKET 119
TABLE 45 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 120
TABLE 46 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 120
8.6 TOPICAL 120
8.6.1 RISING PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS 120
TABLE 47 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 121
TABLE 48 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 121
8.7 NASAL 121
8.7.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS 121
TABLE 49 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 122
TABLE 50 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 122
8.8 OCULAR/OPHTHALMIC 122
8.8.1 INCREASING FREQUENCY OF OPTHALMIC DISEASES TO DRIVE MARKET 122
TABLE 51 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 123
TABLE 52 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 123
8.9 INTRAVENOUS 123
8.9.1 HIGH OCCURENCE OF CHRONIC DISEASES TO FUEL MARKET 123
TABLE 53 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 124
TABLE 54 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 124
8.10 OTHER DRUG DELIVERY MODES 124
TABLE 55 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 125
TABLE 56 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 125
9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE 126
9.1 INTRODUCTION 127
FIGURE 36 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 127
TABLE 57 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 128
TABLE 58 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 128
9.2 PLASTIC BOTTLES 129
9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO BOOST MARKET 129
TABLE 59 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 129
TABLE 60 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 129
9.2.2 STANDARD PLASTIC BOTTLES 130
9.2.3 PLASTIC DISPENSING BOTTLES 130
9.2.4 PLASTIC JARS 130
9.3 BLISTER PACKS 130
9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET 130
TABLE 61 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 131
TABLE 62 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 131
9.3.2 COMPARTMENT PACKS 131
9.3.3 WALLET PACKS 131
9.4 LABELS & ACCESSORIES 132
9.4.1 NEED FOR STRINGENT GUIDELINES ON DRUG INSTRUCTIONS TO FUEL DEMAND 132
TABLE 63 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 132
TABLE 64 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 132
9.4.2 SELF ADHESIVE 133
9.4.3 DIE CUT 133
9.4.4 HOLOGRAPHIC STRIPS 133
9.4.5 TAMPER PROOF 133
9.4.6 OTHER LABELS 133
9.5 CAPS & CLOSURES 134
9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET 134
TABLE 65 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 134
TABLE 66 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 135
9.6 MEDICAL SPECIALTY BAGS 135
9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND 135
TABLE 67 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 135
TABLE 68 MEDICAL SPECIALTY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 136
9.7 PREFILLED SYRINGES 136
9.7.1 RISING NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET 136
TABLE 69 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 137
TABLE 70 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 137
9.8 TEMPERATURE-CONTROLLED PACKAGING 137
9.8.1 SURGING DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET 137
TABLE 71 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 138
TABLE 72 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 138
9.9 POUCHES & STRIP PACKS 139
9.9.1 INCREASING DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET 139
TABLE 73 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 139
TABLE 74 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 139
9.10 AMPOULES 140
9.10.1 HIGH REQUIREMENT FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET 140
TABLE 75 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 140
TABLE 76 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 140
9.11 VIALS 141
9.11.1 CONSISTENT DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE MARKET 141
TABLE 77 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 141
TABLE 78 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 141
9.12 PREFILLED INHALERS 142
9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET 142
TABLE 79 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 142
TABLE 80 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 142
9.12.2 METERED DOSE INHALERS 143
9.12.3 DRY POWDER INHALERS 143
9.13 MEDICATION TUBES 143
9.13.1 INCREASING DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET 143
TABLE 81 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 144
TABLE 82 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 144
9.13.2 COMPOSITE TUBES 144
9.13.3 ALL-PLASTIC TUBES 144
9.13.4 COLLAPSIBLE METAL TUBES 144
9.14 JARS & CANISTERS 145
9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS 145
TABLE 83 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 145
TABLE 84 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 145
9.15 CARTRIDGES 146
9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET 146
TABLE 85 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 146
TABLE 86 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 146
9.16 OTHER TYPES 147
TABLE 87 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 147
TABLE 88 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 147
10 PHARMACEUTICAL PACKAGING MARKET, BY REGION 148
10.1 INTRODUCTION 149
FIGURE 37 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 149
TABLE 89 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION) 149
TABLE 90 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION) 150
10.2 NORTH AMERICA 150
10.2.1 RECESSION IMPACT 150
FIGURE 38 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 151
TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION) 151
TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 152
TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 152
TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 153
TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION) 153
TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION) 153
TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION) 154
TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION) 154
TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION) 155
TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION) 155
TABLE 101 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON) 155
TABLE 102 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON) 156
10.2.2 US 156
10.2.2.1 Rapid technological advancements in pharmaceutical packaging to drive market 156
TABLE 103 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 157
TABLE 104 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 158
10.2.3 CANADA 158
10.2.3.1 Competitive business environment to boost market 158
TABLE 105 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 159
TABLE 106 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 160
10.2.4 MEXICO 160
10.2.4.1 Government initiatives in healthcare industry to fuel demand for pharmaceutical products 160
TABLE 107 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 161
TABLE 108 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 162
10.3 EUROPE 162
10.3.1 RECESSION IMPACT 163
FIGURE 39 EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 163
TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION) 164
TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 164
TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 165
TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 165
TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION) 166
TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION) 166
TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION) 166
TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION) 167
TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION) 167
TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION) 167
TABLE 119 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON) 168
TABLE 120 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON) 168
10.3.2 GERMANY 168
10.3.2.1 Increase in aging population and noncommunicable diseases to drive market 168
TABLE 121 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 169
TABLE 122 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 169
10.3.3 FRANCE 170
10.3.3.1 High demand for generic drugs to drive market 170
TABLE 123 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 171
TABLE 124 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 171
10.3.4 ITALY 172
10.3.4.1 Rising exports of pharmaceutical products to boost market 172
TABLE 125 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 172
TABLE 126 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 173
10.3.5 UK 173
10.3.5.1 Innovations in drug manufacturing to drive market 173
TABLE 127 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 174
TABLE 128 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 175
10.3.6 SPAIN 175
10.3.6.1 Government initiatives in healthcare sector to boost demand 175
TABLE 129 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 176
TABLE 130 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 177
10.3.7 RUSSIA 177
10.3.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market 177
TABLE 131 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 178
TABLE 132 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 179
10.3.8 REST OF EUROPE 179
TABLE 133 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 180
TABLE 134 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 181
10.4 ASIA PACIFIC 181
10.4.1 RECESSION IMPACT 182
FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT 182
TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION) 183
TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 183
TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 184
TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 184
TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION) 185
TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION) 185
TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION) 185
TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION) 186
TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION) 186
TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION) 186
TABLE 145 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON) 187
TABLE 146 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON) 187
10.4.2 CHINA 188
10.4.2.1 Increased investments in biologics and biosimilar drug research to drive market 188
TABLE 147 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 189
TABLE 148 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 189
10.4.3 JAPAN 190
10.4.3.1 Rise in aging population to drive demand for medications 190
TABLE 149 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 191
TABLE 150 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 191
10.4.4 SOUTH KOREA 192
10.4.4.1 Well-developed healthcare industry and presence of major pharmaceuticals manufacturers to drive market 192
TABLE 151 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 193
TABLE 152 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 193
10.4.5 INDIA 194
10.4.5.1 Large domestic consumption and export of generic drugs to drive market 194
TABLE 153 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 194
TABLE 154 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 195
10.4.6 AUSTRALIA 195
10.4.6.1 Wide adoption of Medicare and PBS schemes to drive market 195
TABLE 155 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 196
TABLE 156 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 196
10.4.7 REST OF ASIA PACIFIC 197
TABLE 157 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 197
TABLE 158 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 198
10.5 SOUTH AMERICA 198
10.5.1 RECESSION IMPACT 199
TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION) 199
TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 199
TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 200
TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 200
TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION) 201
TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION) 201
TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION) 201
TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION) 202
TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION) 202
TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION) 202
TABLE 169 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON) 203
TABLE 170 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON) 203
10.5.2 BRAZIL 203
10.5.2.1 Free and universal healthcare services to boost market 203
TABLE 171 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 204
TABLE 172 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 205
10.5.3 ARGENTINA 205
10.5.3.1 Rapid urbanization and increase in import of drugs to fuel market 205
TABLE 173 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 206
TABLE 174 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 206
10.5.4 REST OF SOUTH AMERICA 207
TABLE 175 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 207
TABLE 176 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 208
10.6 MIDDLE EAST & AFRICA 208
10.6.1 RECESSION IMPACT 209
TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION) 209
TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION) 209
TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 210
TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 210
TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION) 211
TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION) 211
TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION) 211
TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION) 212
TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION) 212
TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION) 212
TABLE 187 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON) 213
TABLE 188 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON) 213
10.6.2 GCC 214
10.6.2.1 UAE 214
10.6.2.1.1 Increasing initiatives for domestic pharmaceutical production to drive market 214
TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 214
TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 215
10.6.2.2 Saudi Arabia 215
10.6.2.2.1 More comprehensive access to healthcare services to fuel demand for pharmaceuticals 215
TABLE 191 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 216
TABLE 192 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 217
10.6.2.3 Rest of GCC 217
10.6.3 SOUTH AFRICA 217
10.6.3.1 Gradual rise in use of generic drugs to drive market 217
TABLE 193 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 218
TABLE 194 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 219
10.6.4 REST OF MIDDLE EAST & AFRICA 219
TABLE 195 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION) 220
TABLE 196 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION) 220
11 COMPETITIVE LANDSCAPE 221
11.1 OVERVIEW 221
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN 222
FIGURE 41 OVERVIEW OF KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2019 AND 2023 222
11.3 REVENUE ANALYSIS 223
FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022) 223
11.4 MARKET SHARE ANALYSIS 223
11.4.1 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2022 223
FIGURE 43 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2022 223
11.4.2 MARKET SHARE OF KEY PLAYERS, 2022 224
FIGURE 44 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2022) 225
TABLE 197 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION 225
11.5 COMPANY EVALUATION MATRIX 225
11.5.1 STARS 225
11.5.2 EMERGING LEADERS 225
11.5.3 PERVASIVE PLAYERS 225
11.5.4 PARTICIPANTS 226
FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX, 2022 226
11.5.5 COMPANY FOOTPRINT 227
TABLE 198 PACKAGING TYPE FOOTPRINT (25 COMPANIES) 227
TABLE 199 DRUG DELIVERY MODE FOOTPRINT (25 COMPANIES) 228
TABLE 200 REGION FOOTPRINT (25 COMPANIES) 229
TABLE 201 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 230
11.6 START-UP/SME EVALUATION MATRIX 231
11.6.1 PROGRESSIVE COMPANIES 231
11.6.2 RESPONSIVE COMPANIES 231
11.6.3 DYNAMIC COMPANIES 231
11.6.4 STARTING BLOCKS 231
FIGURE 46 PHARMACEUTICAL PACKAGING MARKET: START-UP/SME EVALUATION MATRIX, 2022 232
11.6.5 COMPETITIVE BENCHMARKING 233
TABLE 202 PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES (25 COMPANIES) 233
11.7 COMPETITIVE SCENARIO AND TRENDS 234
11.7.1 PRODUCT LAUNCHES/DEVELOPMENTS 235
TABLE 203 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES/ DEVELOPMENTS, 2019–2023 235
11.7.2 DEALS 238
TABLE 204 PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2023 238
11.7.3 OTHER DEVELOPMENTS 241
TABLE 205 PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS,
2019–2023 241
12 COMPANY PROFILES 246
(Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats) *
12.1 KEY PLAYERS 246
12.1.1 BERRY GLOBAL INC. 246
TABLE 206 BERRY GLOBAL INC.: COMPANY OVERVIEW 246
FIGURE 47 BERRY GLOBAL INC.: COMPANY SNAPSHOT 247
TABLE 207 BERRY GLOBAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 247
TABLE 208 BERRY GLOBAL INC.: PRODUCT LAUNCHES 248
TABLE 209 BERRY GLOBAL INC.: DEALS 249
TABLE 210 BERRY GLOBAL INC.: OTHER DEVELOPMENTS 249
12.1.2 GERRESHEIMER AG 251
TABLE 211 GERRESHEIMER AG: COMPANY OVERVIEW 251
FIGURE 48 GERRESHEIMER AG: COMPANY SNAPSHOT 251
TABLE 212 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 213 GERRESHEIMER AG: PRODUCT LAUNCHES 253
TABLE 214 GERRESHEIMER AG: DEALS 253
TABLE 215 GERRESHEIMER AG: OTHER DEVELOPMENTS 254
12.1.3 AMCOR PLC 256
TABLE 216 AMCOR PLC: COMPANY OVERVIEW 256
FIGURE 49 AMCOR PLC: COMPANY SNAPSHOT 257
TABLE 217 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 257
TABLE 218 AMCOR PLC: PRODUCT LAUNCHES 259
TABLE 219 AMCOR PLC: DEALS 259
TABLE 220 AMCOR PLC: OTHER DEVELOPMENTS 260
12.1.4 SCHOTT AG 261
TABLE 221 SCHOTT AG: COMPANY OVERVIEW 261
FIGURE 50 SCHOTT AG: COMPANY SNAPSHOT 262
TABLE 222 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 262
TABLE 223 SCHOTT AG: PRODUCT LAUNCHES 263
TABLE 224 SCHOTT AG: DEALS 263
TABLE 225 SCHOTT AG: OTHER DEVELOPMENTS 264
12.1.5 APTARGROUP, INC. 266
TABLE 226 APTARGROUP, INC.: COMPANY OVERVIEW 266
FIGURE 51 APTARGROUP, INC.: COMPANY SNAPSHOT 267
TABLE 227 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 267
TABLE 228 APTARGROUP, INC.: PRODUCT LAUNCHES 268
TABLE 229 APTARGROUP, INC.: DEALS 269
TABLE 230 APTARGROUP, INC.: OTHER DEVELOPMENTS 269
12.1.6 BD 271
TABLE 231 BD: COMPANY OVERVIEW 271
FIGURE 52 BD: COMPANY SNAPSHOT 271
TABLE 232 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 272
TABLE 233 BD: PRODUCT LAUNCHES 272
TABLE 234 BD: DEALS 273
TABLE 235 BD: OTHER DEVELOPMENTS 273
12.1.7 WESTROCK COMPANY 274
TABLE 236 WESTROCK COMPANY: COMPANY OVERVIEW 274
FIGURE 53 WESTROCK COMPANY: COMPANY SNAPSHOT 274
TABLE 237 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
TABLE 238 WESTROCK COMPANY: DEALS 275
TABLE 239 WESTROCK COMPANY: OTHER DEVELOPMENTS 275
12.1.8 NIPRO CORPORATION 276
TABLE 240 NIPRO CORPORATION: COMPANY OVERVIEW 276
FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT 276
TABLE 241 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 277
TABLE 242 NIPRO CORPORATION: PRODUCT LAUNCHES 277
TABLE 243 NIPRO CORPORATION: DEALS 278
12.1.9 CATALENT, INC. 279
TABLE 244 CATALENT, INC.: COMPANY OVERVIEW 279
FIGURE 55 CATALENT, INC.: COMPANY SNAPSHOT 279
TABLE 245 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 280
TABLE 246 CATALENT, INC.: DEALS 280
TABLE 247 CATALENT, INC.: OTHER DEVELOPMENTS 281
12.1.10 SEALED AIR 282
TABLE 248 SEALED AIR: COMPANY OVERVIEW 282
FIGURE 56 SEALED AIR: COMPANY SNAPSHOT 282
TABLE 249 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED 283
TABLE 250 SEALED AIR: PRODUCT LAUNCHES 283
TABLE 251 SEALED AIR: DEALS 284
12.1.11 WEST PHARMACEUTICAL SERVICES, INC. 285
TABLE 252 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW 285
FIGURE 57 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT 285
TABLE 253 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 286
TABLE 254 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES 286
TABLE 255 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS 287
*Details on Business overview, Products/Solutions/Services offered, Recent Developments, MnM view, Right to win, Strategic choices, Weaknesses and competitive threats might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 288
12.2.1 ALPLA 288
TABLE 256 ALPLA: COMPANY OVERVIEW 288
12.2.2 ARDAGH GROUP S.A. 289
TABLE 257 ARDAGH GROUP S.A.: COMPANY OVERVIEW 289
12.2.3 CCL INDUSTRIES INC. 290
TABLE 258 CCL INDUSTRIES INC.: COMPANY OVERVIEW 290
12.2.4 FRANK NOE 291
TABLE 259 FRANK NOE: COMPANY OVERVIEW 291
12.2.5 GAPLAST GMBH 292
TABLE 260 GAPLAST GMBH: COMPANY OVERVIEW 292
12.2.6 LONZA 293
TABLE 261 LONZA: COMPANY OVERVIEW 293
12.2.7 MONDI GROUP 294
TABLE 262 MONDI GROUP: COMPANY OVERVIEW 294
12.2.8 NOLATO AB 295
TABLE 263 NOLATO AB: COMPANY OVERVIEW 295
12.2.9 ORIGIN PHARMA PACKAGING 296
TABLE 264 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW 296
12.2.10 COMAR 297
TABLE 265 COMAR: COMPANY OVERVIEW 297
12.2.11 BILCARE LIMITED 298
TABLE 266 BILCARE LIMITED: COMPANY OVERVIEW 298
12.2.12 SGD PHARMA 299
TABLE 267 SGD PHARMA: COMPANY OVERVIEW 299
12.2.13 SILGAN HOLDINGS INC. 300
TABLE 268 SILGAN HOLDINGS INC.: COMPANY OVERVIEW 300
12.2.14 VETTER PHARMA INTERNATIONAL GMBH 301
TABLE 269 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW 301
13 APPENDIX 302
13.1 DISCUSSION GUIDE 302
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 307
13.3 CUSTOMIZATION OPTIONS 309
13.4 RELATED REPORTS 309
13.5 AUTHOR DETAILS 310